Summary

The global CD63 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
CD63 antibody is a mouse, rabbit, pig and human antibody against CD63. CD63 was recognized in immunohistochemical staining and western blot.
Growing patient base, launch of CD63 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD63 antibody market revenue.
LP Information, Inc. (LPI) ' newest research report, the “CD63 Antibody Industry Forecast” looks at past sales and reviews total world CD63 Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected CD63 Antibody sales for 2026 through 2032. With CD63 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CD63 Antibody industry.
This Insight Report provides a comprehensive analysis of the global CD63 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CD63 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CD63 Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CD63 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CD63 Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of CD63 Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Monoclonal
Polyclonal
Segmentation by Application:
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Thermo Fisher Scientific
NSJ Bioreagents
LifeSpan BioSciences
Bioss
GeneTex
BioLegend
Leading Biology
RayBiotech
OriGene Technologies
Abnova Corporation
Abbexa
ProSci
Bio-Rad
EpiGentek
HUABIO
R and D Systems
BosterBio
Cell Signaling Technology
Novus Biologicals
Biobyt
Jingjie PTM BioLab
Key Questions Addressed in this Report
What is the 10-year outlook for the global CD63 Antibody market?
What factors are driving CD63 Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do CD63 Antibody market opportunities vary by end market size?
How does CD63 Antibody break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global CD63 Antibody Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for CD63 Antibody by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for CD63 Antibody by Country/Region, 2021, 2025 & 2032
2.2 CD63 Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.2.3 CD63 Antibody Sales by Type
2.2.3.1 Global CD63 Antibody Sales Market Share by Type (2021-2026)
2.2.3.2 Global CD63 Antibody Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global CD63 Antibody Sale Price by Type (2021-2026)
2.3 CD63 Antibody Segment by Application
2.3.1 Immunochemistry (IHC)
2.3.2 Immunofluorescence (IF)
2.3.3 Immunoprecipitation (IP)
2.3.4 Western Blot (WB)
2.3.5 ELISA
2.3.6 Others
2.3.7 CD63 Antibody Sales by Application
2.3.7.1 Global CD63 Antibody Sale Market Share by Application (2021-2026)
2.3.7.2 Global CD63 Antibody Revenue and Market Share by Application (2021-2026)
2.3.7.3 Global CD63 Antibody Sale Price by Application (2021-2026)

3 Global by Company
3.1 Global CD63 Antibody Breakdown Data by Company
3.1.1 Global CD63 Antibody Annual Sales by Company (2021-2026)
3.1.2 Global CD63 Antibody Sales Market Share by Company (2021-2026)
3.2 Global CD63 Antibody Annual Revenue by Company (2021-2026)
3.2.1 Global CD63 Antibody Revenue by Company (2021-2026)
3.2.2 Global CD63 Antibody Revenue Market Share by Company (2021-2026)
3.3 Global CD63 Antibody Sale Price by Company
3.4 Key Manufacturers CD63 Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD63 Antibody Product Location Distribution
3.4.2 Players CD63 Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 World Historic Review for CD63 Antibody by Geographic Region
4.1 World Historic CD63 Antibody Market Size by Geographic Region (2021-2026)
4.1.1 Global CD63 Antibody Annual Sales by Geographic Region (2021-2026)
4.1.2 Global CD63 Antibody Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic CD63 Antibody Market Size by Country/Region (2021-2026)
4.2.1 Global CD63 Antibody Annual Sales by Country/Region (2021-2026)
4.2.2 Global CD63 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas CD63 Antibody Sales Growth
4.4 APAC CD63 Antibody Sales Growth
4.5 Europe CD63 Antibody Sales Growth
4.6 Middle East & Africa CD63 Antibody Sales Growth

5 Americas
5.1 Americas CD63 Antibody Sales by Country
5.1.1 Americas CD63 Antibody Sales by Country (2021-2026)
5.1.2 Americas CD63 Antibody Revenue by Country (2021-2026)
5.2 Americas CD63 Antibody Sales by Type (2021-2026)
5.3 Americas CD63 Antibody Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC CD63 Antibody Sales by Region
6.1.1 APAC CD63 Antibody Sales by Region (2021-2026)
6.1.2 APAC CD63 Antibody Revenue by Region (2021-2026)
6.2 APAC CD63 Antibody Sales by Type (2021-2026)
6.3 APAC CD63 Antibody Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 Europe
7.1 Europe CD63 Antibody by Country
7.1.1 Europe CD63 Antibody Sales by Country (2021-2026)
7.1.2 Europe CD63 Antibody Revenue by Country (2021-2026)
7.2 Europe CD63 Antibody Sales by Type (2021-2026)
7.3 Europe CD63 Antibody Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa CD63 Antibody by Country
8.1.1 Middle East & Africa CD63 Antibody Sales by Country (2021-2026)
8.1.2 Middle East & Africa CD63 Antibody Revenue by Country (2021-2026)
8.2 Middle East & Africa CD63 Antibody Sales by Type (2021-2026)
8.3 Middle East & Africa CD63 Antibody Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD63 Antibody
10.3 Manufacturing Process Analysis of CD63 Antibody
10.4 Industry Chain Structure of CD63 Antibody

11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD63 Antibody Distributors
11.3 CD63 Antibody Customer

12 World Forecast Review for CD63 Antibody by Geographic Region
12.1 Global CD63 Antibody Market Size Forecast by Region
12.1.1 Global CD63 Antibody Forecast by Region (2027-2032)
12.1.2 Global CD63 Antibody Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global CD63 Antibody Forecast by Type (2027-2032)
12.7 Global CD63 Antibody Forecast by Application (2027-2032)

13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck CD63 Antibody Product Portfolios and Specifications
13.1.3 Merck CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific CD63 Antibody Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 NSJ Bioreagents
13.3.1 NSJ Bioreagents Company Information
13.3.2 NSJ Bioreagents CD63 Antibody Product Portfolios and Specifications
13.3.3 NSJ Bioreagents CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 NSJ Bioreagents Main Business Overview
13.3.5 NSJ Bioreagents Latest Developments
13.4 LifeSpan BioSciences
13.4.1 LifeSpan BioSciences Company Information
13.4.2 LifeSpan BioSciences CD63 Antibody Product Portfolios and Specifications
13.4.3 LifeSpan BioSciences CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 LifeSpan BioSciences Main Business Overview
13.4.5 LifeSpan BioSciences Latest Developments
13.5 Bioss
13.5.1 Bioss Company Information
13.5.2 Bioss CD63 Antibody Product Portfolios and Specifications
13.5.3 Bioss CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Bioss Main Business Overview
13.5.5 Bioss Latest Developments
13.6 GeneTex
13.6.1 GeneTex Company Information
13.6.2 GeneTex CD63 Antibody Product Portfolios and Specifications
13.6.3 GeneTex CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GeneTex Main Business Overview
13.6.5 GeneTex Latest Developments
13.7 BioLegend
13.7.1 BioLegend Company Information
13.7.2 BioLegend CD63 Antibody Product Portfolios and Specifications
13.7.3 BioLegend CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BioLegend Main Business Overview
13.7.5 BioLegend Latest Developments
13.8 Leading Biology
13.8.1 Leading Biology Company Information
13.8.2 Leading Biology CD63 Antibody Product Portfolios and Specifications
13.8.3 Leading Biology CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Leading Biology Main Business Overview
13.8.5 Leading Biology Latest Developments
13.9 RayBiotech
13.9.1 RayBiotech Company Information
13.9.2 RayBiotech CD63 Antibody Product Portfolios and Specifications
13.9.3 RayBiotech CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 RayBiotech Main Business Overview
13.9.5 RayBiotech Latest Developments
13.10 OriGene Technologies
13.10.1 OriGene Technologies Company Information
13.10.2 OriGene Technologies CD63 Antibody Product Portfolios and Specifications
13.10.3 OriGene Technologies CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 OriGene Technologies Main Business Overview
13.10.5 OriGene Technologies Latest Developments
13.11 Abnova Corporation
13.11.1 Abnova Corporation Company Information
13.11.2 Abnova Corporation CD63 Antibody Product Portfolios and Specifications
13.11.3 Abnova Corporation CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Abnova Corporation Main Business Overview
13.11.5 Abnova Corporation Latest Developments
13.12 Abbexa
13.12.1 Abbexa Company Information
13.12.2 Abbexa CD63 Antibody Product Portfolios and Specifications
13.12.3 Abbexa CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Abbexa Main Business Overview
13.12.5 Abbexa Latest Developments
13.13 ProSci
13.13.1 ProSci Company Information
13.13.2 ProSci CD63 Antibody Product Portfolios and Specifications
13.13.3 ProSci CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ProSci Main Business Overview
13.13.5 ProSci Latest Developments
13.14 Bio-Rad
13.14.1 Bio-Rad Company Information
13.14.2 Bio-Rad CD63 Antibody Product Portfolios and Specifications
13.14.3 Bio-Rad CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Bio-Rad Main Business Overview
13.14.5 Bio-Rad Latest Developments
13.15 EpiGentek
13.15.1 EpiGentek Company Information
13.15.2 EpiGentek CD63 Antibody Product Portfolios and Specifications
13.15.3 EpiGentek CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 EpiGentek Main Business Overview
13.15.5 EpiGentek Latest Developments
13.16 HUABIO
13.16.1 HUABIO Company Information
13.16.2 HUABIO CD63 Antibody Product Portfolios and Specifications
13.16.3 HUABIO CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 HUABIO Main Business Overview
13.16.5 HUABIO Latest Developments
13.17 R and D Systems
13.17.1 R and D Systems Company Information
13.17.2 R and D Systems CD63 Antibody Product Portfolios and Specifications
13.17.3 R and D Systems CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 R and D Systems Main Business Overview
13.17.5 R and D Systems Latest Developments
13.18 BosterBio
13.18.1 BosterBio Company Information
13.18.2 BosterBio CD63 Antibody Product Portfolios and Specifications
13.18.3 BosterBio CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 BosterBio Main Business Overview
13.18.5 BosterBio Latest Developments
13.19 Cell Signaling Technology
13.19.1 Cell Signaling Technology Company Information
13.19.2 Cell Signaling Technology CD63 Antibody Product Portfolios and Specifications
13.19.3 Cell Signaling Technology CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Cell Signaling Technology Main Business Overview
13.19.5 Cell Signaling Technology Latest Developments
13.20 Novus Biologicals
13.20.1 Novus Biologicals Company Information
13.20.2 Novus Biologicals CD63 Antibody Product Portfolios and Specifications
13.20.3 Novus Biologicals CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Novus Biologicals Main Business Overview
13.20.5 Novus Biologicals Latest Developments
13.21 Biobyt
13.21.1 Biobyt Company Information
13.21.2 Biobyt CD63 Antibody Product Portfolios and Specifications
13.21.3 Biobyt CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Biobyt Main Business Overview
13.21.5 Biobyt Latest Developments
13.22 Jingjie PTM BioLab
13.22.1 Jingjie PTM BioLab Company Information
13.22.2 Jingjie PTM BioLab CD63 Antibody Product Portfolios and Specifications
13.22.3 Jingjie PTM BioLab CD63 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Jingjie PTM BioLab Main Business Overview
13.22.5 Jingjie PTM BioLab Latest Developments

14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. CD63 Antibody Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. CD63 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. Global CD63 Antibody Sales by Type (2021-2026) & (L)
Table 6. Global CD63 Antibody Sales Market Share by Type (2021-2026)
Table 7. Global CD63 Antibody Revenue by Type (2021-2026) & ($ million)
Table 8. Global CD63 Antibody Revenue Market Share by Type (2021-2026)
Table 9. Global CD63 Antibody Sale Price by Type (2021-2026) & (US$/L)
Table 10. Global CD63 Antibody Sale by Application (2021-2026) & (L)
Table 11. Global CD63 Antibody Sale Market Share by Application (2021-2026)
Table 12. Global CD63 Antibody Revenue by Application (2021-2026) & ($ million)
Table 13. Global CD63 Antibody Revenue Market Share by Application (2021-2026)
Table 14. Global CD63 Antibody Sale Price by Application (2021-2026) & (US$/L)
Table 15. Global CD63 Antibody Sales by Company (2021-2026) & (L)
Table 16. Global CD63 Antibody Sales Market Share by Company (2021-2026)
Table 17. Global CD63 Antibody Revenue by Company (2021-2026) & ($ millions)
Table 18. Global CD63 Antibody Revenue Market Share by Company (2021-2026)
Table 19. Global CD63 Antibody Sale Price by Company (2021-2026) & (US$/L)
Table 20. Key Manufacturers CD63 Antibody Producing Area Distribution and Sales Area
Table 21. Players CD63 Antibody Products Offered
Table 22. CD63 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global CD63 Antibody Sales by Geographic Region (2021-2026) & (L)
Table 26. Global CD63 Antibody Sales Market Share Geographic Region (2021-2026)
Table 27. Global CD63 Antibody Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global CD63 Antibody Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global CD63 Antibody Sales by Country/Region (2021-2026) & (L)
Table 30. Global CD63 Antibody Sales Market Share by Country/Region (2021-2026)
Table 31. Global CD63 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global CD63 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas CD63 Antibody Sales by Country (2021-2026) & (L)
Table 34. Americas CD63 Antibody Sales Market Share by Country (2021-2026)
Table 35. Americas CD63 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas CD63 Antibody Sales by Type (2021-2026) & (L)
Table 37. Americas CD63 Antibody Sales by Application (2021-2026) & (L)
Table 38. APAC CD63 Antibody Sales by Region (2021-2026) & (L)
Table 39. APAC CD63 Antibody Sales Market Share by Region (2021-2026)
Table 40. APAC CD63 Antibody Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC CD63 Antibody Sales by Type (2021-2026) & (L)
Table 42. APAC CD63 Antibody Sales by Application (2021-2026) & (L)
Table 43. Europe CD63 Antibody Sales by Country (2021-2026) & (L)
Table 44. Europe CD63 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe CD63 Antibody Sales by Type (2021-2026) & (L)
Table 46. Europe CD63 Antibody Sales by Application (2021-2026) & (L)
Table 47. Middle East & Africa CD63 Antibody Sales by Country (2021-2026) & (L)
Table 48. Middle East & Africa CD63 Antibody Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa CD63 Antibody Sales by Type (2021-2026) & (L)
Table 50. Middle East & Africa CD63 Antibody Sales by Application (2021-2026) & (L)
Table 51. Key Market Drivers & Growth Opportunities of CD63 Antibody
Table 52. Key Market Challenges & Risks of CD63 Antibody
Table 53. Key Industry Trends of CD63 Antibody
Table 54. CD63 Antibody Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. CD63 Antibody Distributors List
Table 57. CD63 Antibody Customer List
Table 58. Global CD63 Antibody Sales Forecast by Region (2027-2032) & (L)
Table 59. Global CD63 Antibody Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas CD63 Antibody Sales Forecast by Country (2027-2032) & (L)
Table 61. Americas CD63 Antibody Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC CD63 Antibody Sales Forecast by Region (2027-2032) & (L)
Table 63. APAC CD63 Antibody Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe CD63 Antibody Sales Forecast by Country (2027-2032) & (L)
Table 65. Europe CD63 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa CD63 Antibody Sales Forecast by Country (2027-2032) & (L)
Table 67. Middle East & Africa CD63 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global CD63 Antibody Sales Forecast by Type (2027-2032) & (L)
Table 69. Global CD63 Antibody Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global CD63 Antibody Sales Forecast by Application (2027-2032) & (L)
Table 71. Global CD63 Antibody Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck CD63 Antibody Product Portfolios and Specifications
Table 74. Merck CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Thermo Fisher Scientific Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 78. Thermo Fisher Scientific CD63 Antibody Product Portfolios and Specifications
Table 79. Thermo Fisher Scientific CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 80. Thermo Fisher Scientific Main Business
Table 81. Thermo Fisher Scientific Latest Developments
Table 82. NSJ Bioreagents Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 83. NSJ Bioreagents CD63 Antibody Product Portfolios and Specifications
Table 84. NSJ Bioreagents CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 85. NSJ Bioreagents Main Business
Table 86. NSJ Bioreagents Latest Developments
Table 87. LifeSpan BioSciences Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 88. LifeSpan BioSciences CD63 Antibody Product Portfolios and Specifications
Table 89. LifeSpan BioSciences CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 90. LifeSpan BioSciences Main Business
Table 91. LifeSpan BioSciences Latest Developments
Table 92. Bioss Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. Bioss CD63 Antibody Product Portfolios and Specifications
Table 94. Bioss CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 95. Bioss Main Business
Table 96. Bioss Latest Developments
Table 97. GeneTex Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. GeneTex CD63 Antibody Product Portfolios and Specifications
Table 99. GeneTex CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 100. GeneTex Main Business
Table 101. GeneTex Latest Developments
Table 102. BioLegend Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. BioLegend CD63 Antibody Product Portfolios and Specifications
Table 104. BioLegend CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 105. BioLegend Main Business
Table 106. BioLegend Latest Developments
Table 107. Leading Biology Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. Leading Biology CD63 Antibody Product Portfolios and Specifications
Table 109. Leading Biology CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 110. Leading Biology Main Business
Table 111. Leading Biology Latest Developments
Table 112. RayBiotech Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. RayBiotech CD63 Antibody Product Portfolios and Specifications
Table 114. RayBiotech CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 115. RayBiotech Main Business
Table 116. RayBiotech Latest Developments
Table 117. OriGene Technologies Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. OriGene Technologies CD63 Antibody Product Portfolios and Specifications
Table 119. OriGene Technologies CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 120. OriGene Technologies Main Business
Table 121. OriGene Technologies Latest Developments
Table 122. Abnova Corporation Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. Abnova Corporation CD63 Antibody Product Portfolios and Specifications
Table 124. Abnova Corporation CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 125. Abnova Corporation Main Business
Table 126. Abnova Corporation Latest Developments
Table 127. Abbexa Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. Abbexa CD63 Antibody Product Portfolios and Specifications
Table 129. Abbexa CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 130. Abbexa Main Business
Table 131. Abbexa Latest Developments
Table 132. ProSci Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. ProSci CD63 Antibody Product Portfolios and Specifications
Table 134. ProSci CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 135. ProSci Main Business
Table 136. ProSci Latest Developments
Table 137. Bio-Rad Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. Bio-Rad CD63 Antibody Product Portfolios and Specifications
Table 139. Bio-Rad CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 140. Bio-Rad Main Business
Table 141. Bio-Rad Latest Developments
Table 142. EpiGentek Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. EpiGentek CD63 Antibody Product Portfolios and Specifications
Table 144. EpiGentek CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 145. EpiGentek Main Business
Table 146. EpiGentek Latest Developments
Table 147. HUABIO Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. HUABIO CD63 Antibody Product Portfolios and Specifications
Table 149. HUABIO CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 150. HUABIO Main Business
Table 151. HUABIO Latest Developments
Table 152. R and D Systems Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. R and D Systems CD63 Antibody Product Portfolios and Specifications
Table 154. R and D Systems CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 155. R and D Systems Main Business
Table 156. R and D Systems Latest Developments
Table 157. BosterBio Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 158. BosterBio CD63 Antibody Product Portfolios and Specifications
Table 159. BosterBio CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 160. BosterBio Main Business
Table 161. BosterBio Latest Developments
Table 162. Cell Signaling Technology Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 163. Cell Signaling Technology CD63 Antibody Product Portfolios and Specifications
Table 164. Cell Signaling Technology CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 165. Cell Signaling Technology Main Business
Table 166. Cell Signaling Technology Latest Developments
Table 167. Novus Biologicals Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 168. Novus Biologicals CD63 Antibody Product Portfolios and Specifications
Table 169. Novus Biologicals CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 170. Novus Biologicals Main Business
Table 171. Novus Biologicals Latest Developments
Table 172. Biobyt Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 173. Biobyt CD63 Antibody Product Portfolios and Specifications
Table 174. Biobyt CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 175. Biobyt Main Business
Table 176. Biobyt Latest Developments
Table 177. Jingjie PTM BioLab Basic Information, CD63 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 178. Jingjie PTM BioLab CD63 Antibody Product Portfolios and Specifications
Table 179. Jingjie PTM BioLab CD63 Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 180. Jingjie PTM BioLab Main Business
Table 181. Jingjie PTM BioLab Latest Developments

List of Figures
Figure 1. Picture of CD63 Antibody
Figure 2. CD63 Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CD63 Antibody Sales Growth Rate 2021-2032 (L)
Figure 7. Global CD63 Antibody Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. CD63 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. CD63 Antibody Sales Market Share by Country/Region (2025)
Figure 10. CD63 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal
Figure 12. Product Picture of Polyclonal
Figure 13. Global CD63 Antibody Sales Market Share by Type in 2026
Figure 14. Global CD63 Antibody Revenue Market Share by Type (2021-2026)
Figure 15. CD63 Antibody Consumed in Immunochemistry (IHC)
Figure 16. Global CD63 Antibody Market: Immunochemistry (IHC) (2021-2026) & (L)
Figure 17. CD63 Antibody Consumed in Immunofluorescence (IF)
Figure 18. Global CD63 Antibody Market: Immunofluorescence (IF) (2021-2026) & (L)
Figure 19. CD63 Antibody Consumed in Immunoprecipitation (IP)
Figure 20. Global CD63 Antibody Market: Immunoprecipitation (IP) (2021-2026) & (L)
Figure 21. CD63 Antibody Consumed in Western Blot (WB)
Figure 22. Global CD63 Antibody Market: Western Blot (WB) (2021-2026) & (L)
Figure 23. CD63 Antibody Consumed in ELISA
Figure 24. Global CD63 Antibody Market: ELISA (2021-2026) & (L)
Figure 25. CD63 Antibody Consumed in Others
Figure 26. Global CD63 Antibody Market: Others (2021-2026) & (L)
Figure 27. Global CD63 Antibody Sale Market Share by Application (2025)
Figure 28. Global CD63 Antibody Revenue Market Share by Application in 2026
Figure 29. CD63 Antibody Sales by Company in 2026 (L)
Figure 30. Global CD63 Antibody Sales Market Share by Company in 2026
Figure 31. CD63 Antibody Revenue by Company in 2026 ($ millions)
Figure 32. Global CD63 Antibody Revenue Market Share by Company in 2026
Figure 33. Global CD63 Antibody Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global CD63 Antibody Revenue Market Share by Geographic Region in 2026
Figure 35. Americas CD63 Antibody Sales 2021-2026 (L)
Figure 36. Americas CD63 Antibody Revenue 2021-2026 ($ millions)
Figure 37. APAC CD63 Antibody Sales 2021-2026 (L)
Figure 38. APAC CD63 Antibody Revenue 2021-2026 ($ millions)
Figure 39. Europe CD63 Antibody Sales 2021-2026 (L)
Figure 40. Europe CD63 Antibody Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa CD63 Antibody Sales 2021-2026 (L)
Figure 42. Middle East & Africa CD63 Antibody Revenue 2021-2026 ($ millions)
Figure 43. Americas CD63 Antibody Sales Market Share by Country in 2026
Figure 44. Americas CD63 Antibody Revenue Market Share by Country (2021-2026)
Figure 45. Americas CD63 Antibody Sales Market Share by Type (2021-2026)
Figure 46. Americas CD63 Antibody Sales Market Share by Application (2021-2026)
Figure 47. United States CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC CD63 Antibody Sales Market Share by Region in 2026
Figure 52. APAC CD63 Antibody Revenue Market Share by Region (2021-2026)
Figure 53. APAC CD63 Antibody Sales Market Share by Type (2021-2026)
Figure 54. APAC CD63 Antibody Sales Market Share by Application (2021-2026)
Figure 55. China CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 59. India CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe CD63 Antibody Sales Market Share by Country in 2026
Figure 63. Europe CD63 Antibody Revenue Market Share by Country (2021-2026)
Figure 64. Europe CD63 Antibody Sales Market Share by Type (2021-2026)
Figure 65. Europe CD63 Antibody Sales Market Share by Application (2021-2026)
Figure 66. Germany CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 67. France CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 68. UK CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa CD63 Antibody Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa CD63 Antibody Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa CD63 Antibody Sales Market Share by Application (2021-2026)
Figure 74. Egypt CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries CD63 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of CD63 Antibody in 2026
Figure 80. Manufacturing Process Analysis of CD63 Antibody
Figure 81. Industry Chain Structure of CD63 Antibody
Figure 82. Channels of Distribution
Figure 83. Global CD63 Antibody Sales Market Forecast by Region (2027-2032)
Figure 84. Global CD63 Antibody Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global CD63 Antibody Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global CD63 Antibody Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global CD63 Antibody Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global CD63 Antibody Revenue Market Share Forecast by Application (2027-2032)